secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2022-06-29T23:59:59+00:00
Accession:  0001558370-22-010449
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor provides top-line update from HOPE-2 open label extension trial
------------------------------------------------------------------------

- Capricor reported top-line results from HOPE-2 OLE (1-year data) via slide presentation on June 27, 2022.
- The slide presentation was made available on the company's website; specific data not detailed in the filing.
- No numerical results or endpoint data are included in the filed exhibit; only a title slide is reproduced.
- The update was disclosed under Regulation FD; a conference call was held the same day.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837022010449/0001558370-22-010449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837022010449/capr-20220627x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-010449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer